Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019)
Protalix BioTherapeutics' (PLX) quarterly Receivables - Other came in at $26000.0 in Q4 2019, down 99.0% quarter-over-quarter from $2.6 million in Q1 2014.
Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019) Analysis & Trends
Protalix BioTherapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $26000.0 for Q4 2019.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $26000.0 in Q4 2019; TTM through Dec 2019 was $26000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $26000.0, changed N/A from the prior year.
- Receivables - Other slipped to $26000.0 in Q4 2019 per PLX's latest filing, from $2.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $26000.0 in Q4 2019 and bottomed at $26000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Mar 31, 2014 | 2.61 Mn |
| Mar 31, 2014 | 2.61 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Mar 31, 2012 | 3.15 Mn |
| Mar 31, 2012 | 3.15 Mn |